郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Submicron Protein Particle Characterization using Resistive Pulse Sensing and Conventional Light Scattering Based Approaches.

期刊：Pharmaceutical research发表年份：2018作者：Gregory V Barnett; Julia M Perhacs; Tapan K Das; Sambit R Kar
阅读更多 →

药效评价Direct evidence for high affinity blockade of NaV1.6 channel subtype by huwentoxin-IV spider peptide, using multiscale functional approaches.

期刊：Neuropharmacology发表年份：2018作者：Tânia C Gonçalves; Rachid Boukaiba; Jordi Molgó; Muriel Amar; Michel Partiseti; Denis Servent; Evelyne Benoit
阅读更多 →

药效评价In vitro and in vivo characterization of the bifunctional μ and δ opioid receptor ligand UFP-505.

期刊：British journal of pharmacology发表年份：2018作者：N Dietis; H Niwa; R Tose; J McDonald; V Ruggieri; M Filaferro; G Vitale; L Micheli; C Ghelardini; S Salvadori; G Calo; R Guerrini; D J Rowbotham; D G Lambert
阅读更多 →

药效评价Synthesis, Pharmacological Evaluation, and Docking Studies of Novel Pyridazinone-Based Cannabinoid Receptor Type 2 Ligands.

期刊：ChemMedChem发表年份：2018作者：Giulio Ragusa; Serena Bencivenni; Paula Morales; Tyra Callaway; Dow P Hurst; Battistina Asproni; Stefania Merighi; Giovanni Loriga; Gerard A Pinna; Patricia H Reggio; Stefania Gessi; Gabriele Murineddu
阅读更多 →